Berglund G, Larsson B, Andersson O, Larsson O, Svärdsudd K, Björntorp P, Wilhelmsen L
Acta Med Scand. 1976;200(3):163-9. doi: 10.1111/j.0954-6820.1976.tb08215.x.
Body fat, body cell mass, fasting blood sugar, glucose tolerance and fasting insulin have been determined in 106 hypertensive males aged 47-54years and in 41 normotensive 50-year-old males. Both groups were derived from screening examinations in random population samples. The hypertensive subjects were more often obese and had more often an impaired glucose tolerance and a higher fasting insulin compared with the normotensive subjects. The metabolic differences were not explained simply by the higher degree of obesity in the hypertensive subjects, as the differences remained when the hypertensive subjects were matched for body fat with normotensive controls. The impaired glucose metabolism demonstrated quantitatively in an unselected group of hypertensive subjects, might be one of the factors explaining the variable prognosis in hypertensive subjects.
对106名年龄在47 - 54岁的男性高血压患者和41名50岁的血压正常男性进行了体脂、体细胞质量、空腹血糖、糖耐量和空腹胰岛素水平的测定。两组均来自随机人群样本的筛查检查。与血压正常的受试者相比,高血压受试者更常肥胖,糖耐量受损的情况更常见,空腹胰岛素水平也更高。代谢差异并非仅仅由高血压受试者更高的肥胖程度所解释,因为当高血压受试者与血压正常的对照组在体脂方面进行匹配时,差异仍然存在。在一组未经挑选的高血压受试者中定量显示的葡萄糖代谢受损,可能是解释高血压患者预后差异的因素之一。